195.21
price up icon0.72%   1.39
after-market アフターアワーズ: 195.21
loading
前日終値:
$193.82
開ける:
$193.99
24時間の取引高:
871.30K
Relative Volume:
0.98
時価総額:
$21.61B
収益:
$11.28B
当期純損益:
$1.07B
株価収益率:
21.53
EPS:
9.0657
ネットキャッシュフロー:
$1.33B
1週間 パフォーマンス:
+4.61%
1か月 パフォーマンス:
-4.31%
6か月 パフォーマンス:
+2.07%
1年 パフォーマンス:
+15.09%
1日の値動き範囲:
Value
$193.96
$196.92
1週間の範囲:
Value
$187.06
$196.92
52週間の値動き範囲:
Value
$164.65
$213.50

Quest Diagnostics Inc Stock (DGX) Company Profile

Name
名前
Quest Diagnostics Inc
Name
セクター
Healthcare (1108)
Name
電話
(973) 520-2700
Name
住所
500 PLAZA DRIVE, SECAUCUS
Name
職員
57,000
Name
Twitter
@QuestDX
Name
次回の収益日
2026-04-21
Name
最新のSEC提出書
Name
DGX's Discussions on Twitter

Compare DGX vs TMO, DHR, IDXX, WAT, A

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
DGX icon
DGX
Quest Diagnostics Inc
195.21 21.46B 11.28B 1.07B 1.33B 9.0657
TMO icon
TMO
Thermo Fisher Scientific Inc
448.28 167.00B 45.20B 6.87B 6.75B 18.19
DHR icon
DHR
Danaher Corp
172.00 122.68B 24.78B 3.68B 5.29B 5.1743
IDXX icon
IDXX
Idexx Laboratories Inc
559.37 43.63B 4.45B 1.10B 1.06B 13.59
WAT icon
WAT
Waters Corp
342.37 33.48B 3.77B 449.25M 240.68M 7.8556
A icon
A
Agilent Technologies Inc
114.96 32.44B 7.07B 1.29B 993.00M 4.5355

Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-01-30 アップグレード Barclays Equal Weight → Overweight
2025-08-25 ダウングレード Robert W. Baird Outperform → Neutral
2025-04-02 開始されました Redburn Atlantic Buy
2025-03-04 ダウングレード Citigroup Buy → Neutral
2025-01-06 アップグレード Leerink Partners Market Perform → Outperform
2024-12-17 アップグレード Morgan Stanley Equal-Weight → Overweight
2024-12-10 再開されました Jefferies Buy
2024-10-23 アップグレード Robert W. Baird Neutral → Outperform
2024-08-28 再開されました Evercore ISI In-line
2024-07-10 アップグレード Citigroup Neutral → Buy
2024-02-26 開始されました Leerink Partners Market Perform
2024-02-07 アップグレード Jefferies Hold → Buy
2024-01-03 開始されました Barclays Equal Weight
2023-12-12 アップグレード BofA Securities Neutral → Buy
2023-06-29 開始されました Piper Sandler Neutral
2023-05-02 ダウングレード BofA Securities Buy → Neutral
2023-04-03 アップグレード Citigroup Sell → Neutral
2023-01-23 開始されました Evercore ISI In-line
2022-11-17 ダウングレード Citigroup Neutral → Sell
2022-08-22 再開されました Morgan Stanley Equal-Weight
2022-04-04 ダウングレード Citigroup Buy → Neutral
2022-02-23 ダウングレード UBS Buy → Neutral
2022-02-02 ダウングレード Jefferies Buy → Hold
2022-01-28 ダウングレード Deutsche Bank Buy → Hold
2021-05-04 アップグレード UBS Neutral → Buy
2021-03-12 ダウングレード Robert W. Baird Outperform → Neutral
2020-10-21 アップグレード Argus Hold → Buy
2020-07-29 アップグレード KeyBanc Capital Markets Sector Weight → Overweight
2020-07-14 アップグレード BofA Securities Neutral → Buy
2020-06-09 アップグレード Wells Fargo Underweight → Equal Weight
2020-06-02 アップグレード Deutsche Bank Hold → Buy
2020-04-28 アップグレード Morgan Stanley Equal-Weight → Overweight
2020-04-27 アップグレード Citigroup Neutral → Buy
2020-04-27 アップグレード Wolfe Research Underperform → Peer Perform
2020-03-27 ダウングレード Morgan Stanley Overweight → Equal-Weight
2020-01-08 開始されました Wells Fargo Underweight
2020-01-07 ダウングレード Barclays Overweight → Equal Weight
2019-12-19 アップグレード BofA/Merrill Underperform → Neutral
2019-07-15 ダウングレード Goldman Neutral → Sell
2019-04-02 アップグレード Jefferies Hold → Buy
2019-03-18 再開されました Credit Suisse Neutral
2019-01-31 ダウングレード Argus Buy → Hold
2019-01-17 開始されました UBS Neutral
2019-01-03 ダウングレード BofA/Merrill Neutral → Underperform
2018-12-03 ダウングレード BofA/Merrill Buy → Neutral
2018-11-30 ダウングレード Goldman Buy → Neutral
すべてを表示

Quest Diagnostics Inc (DGX) 最新ニュース

pulisher
May 22, 2026

Quest Diagnostics 8-K SEC Filing May 2026: Shareholder Vote Results and Company Information - Minichart

May 22, 2026
pulisher
May 21, 2026

Quest Diagnostics (DGX) Announces Results of 2026 Annual Meeting of Stockholders - GuruFocus

May 21, 2026
pulisher
May 21, 2026

Quest Diagnostics shareholders elect directors and approve auditor at annual meeting - Investing.com UK

May 21, 2026
pulisher
May 21, 2026

Quest Diagnostics shareholders elect directors and approve auditor at annual meeting By Investing.com - Investing.com South Africa

May 21, 2026
pulisher
May 21, 2026

Quest Diagnostics (DGX) director granted 1,142 restricted stock units in Form 4 filing - Stock Titan

May 21, 2026
pulisher
May 21, 2026

Director at Quest Diagnostics (NYSE: DGX) receives 1,142 RSUs - Stock Titan

May 21, 2026
pulisher
May 21, 2026

Quest Diagnostics (DGX) director receives 1,142-share restricted stock unit grant - Stock Titan

May 21, 2026
pulisher
May 21, 2026

Quest Diagnostics (DGX) director gets 1,142-share restricted stock unit award - Stock Titan

May 21, 2026
pulisher
May 21, 2026

Director Tracey Doi of Quest Diagnostics (DGX) receives 1,142-share equity award - Stock Titan

May 21, 2026
pulisher
May 21, 2026

Director at Quest Diagnostics (DGX) awarded 1,142 restricted stock units - Stock Titan

May 21, 2026
pulisher
May 21, 2026

Director at Quest Diagnostics (NYSE: DGX) receives 1,142 stock units - Stock Titan

May 21, 2026
pulisher
May 21, 2026

Quest Diagnostics (DGX) director receives 1,142 restricted stock units - Stock Titan

May 21, 2026
pulisher
May 21, 2026

Director at Quest Diagnostics (DGX) receives 1,142 share units - Stock Titan

May 21, 2026
pulisher
May 21, 2026

Quest Diagnostics (NYSE: DGX) details 2026 shareholder votes on board, pay and auditor - Stock Titan

May 21, 2026
pulisher
May 21, 2026

Why is Quest Diagnostics (DGX) down 5% since last earnings report? - MSN

May 21, 2026
pulisher
May 21, 2026

Why Is Quest Diagnostics (DGX) Down 5% Since Last Earnings Report? - Yahoo Finance

May 21, 2026
pulisher
May 20, 2026

Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MarketWatch

May 20, 2026
pulisher
May 19, 2026

Quest Diagnostics Keeps Quarterly Dividend at $0.86 a Share, Payable July 22 to Holders of Record July 8 - marketscreener.com

May 19, 2026
pulisher
May 19, 2026

Quest Diagnostics Declares Quarterly Cash Dividend - Barchart

May 19, 2026
pulisher
May 19, 2026

Guardant Health’s Shield Blood-Based Screening Test for Colorectal Cancer Now Accessible Through National Test Ordering and Collection Network of Quest Diagnostics - Nevada Business Magazine

May 19, 2026
pulisher
May 19, 2026

Is This the Right Time to Hold DGX Stock in Your Portfolio? - TradingView

May 19, 2026
pulisher
May 18, 2026

Quest Diagnostics Incorporated announces Quarterly dividend, payable on July 22, 2026 - marketscreener.com

May 18, 2026
pulisher
May 18, 2026

Baird Adjusts Price Target on Quest Diagnostics to $232 From $229, Maintains Neutral Rating - Moomoo

May 18, 2026
pulisher
May 18, 2026

Quest Diagnostics (NYSE:DGX): A Solid Dividend Play Backed by Strong Profitability and Financial Health - ChartMill

May 18, 2026
pulisher
May 16, 2026

International Assets Investment Management LLC Purchases New Shares in Quest Diagnostics Incorporated $DGX - MarketBeat

May 16, 2026
pulisher
May 15, 2026

Q2 EPS Estimates for Quest Diagnostics Cut by Zacks Research - MarketBeat

May 15, 2026
pulisher
May 15, 2026

173,262 Shares in Quest Diagnostics Incorporated $DGX Bought by Conning Inc. - MarketBeat

May 15, 2026
pulisher
May 14, 2026

How The Investment Narrative For Quest Diagnostics (DGX) Is Shifting With New Valuation Work - Yahoo Finance

May 14, 2026
pulisher
May 13, 2026

Quest Diagnostics Incorporated (NYSE:DGX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

May 13, 2026
pulisher
May 12, 2026

Global HPV Testing and Pap Test Market is Expected to Showcase a Significant Growth at a CAGR of ~7% by 2034 | DelveInsight - GlobeNewswire Inc.

May 12, 2026
pulisher
May 12, 2026

Quest Diagnostics Incorporated $DGX Shares Acquired by Ethic Inc. - MarketBeat

May 12, 2026
pulisher
May 10, 2026

Truist Financial Corp Cuts Stock Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat

May 10, 2026
pulisher
May 09, 2026

Swedbank AB Increases Stake in Quest Diagnostics Incorporated $DGX - MarketBeat

May 09, 2026
pulisher
May 09, 2026

Generali Asset Management SPA SGR Purchases 8,924 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat

May 09, 2026
pulisher
May 08, 2026

Quest Diagnostics Inc. stock underperforms Friday when compared to competitors - MarketWatch

May 08, 2026
pulisher
May 08, 2026

Quest Diagnostics (NYSE: DGX) sells $500M in 5.000% senior notes due 2036 - Stock Titan

May 08, 2026
pulisher
May 07, 2026

Bullish Quarterly Results: 3 Companies Raising Guidance - TradingView

May 07, 2026
pulisher
May 06, 2026

Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term - Yahoo Finance

May 06, 2026
pulisher
May 05, 2026

DGX SEC FilingsQuest Diagnostics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

May 05, 2026
pulisher
May 05, 2026

DGX6380050 Bond Analysis — Key Metrics - TradingView

May 05, 2026
pulisher
May 03, 2026

Quest Diagnostics Incorporated $DGX Shares Sold by Keybank National Association OH - MarketBeat

May 03, 2026
pulisher
May 02, 2026

Quest Diagnostics Incorporated $DGX Shares Acquired by Davis Selected Advisers - MarketBeat

May 02, 2026
pulisher
May 02, 2026

Quest Diagnostics Incorporated $DGX Stock Holdings Increased by Artemis Investment Management LLP - MarketBeat

May 02, 2026
pulisher
May 02, 2026

Quest Diagnostics | 8-K: Current report - Moomoo

May 02, 2026
pulisher
May 01, 2026

Quest Diagnostics Incorporated (NYSE:DGX) Short Interest Update - MarketBeat

May 01, 2026
pulisher
May 01, 2026

Quest Diagnostics prices $500M 5.00% senior notes due 2036 to fund general purposes - TradingView

May 01, 2026
pulisher
May 01, 2026

[8-K] QUEST DIAGNOSTICS INC Reports Material Event - Stock Titan

May 01, 2026
pulisher
May 01, 2026

Quest Diagnostics Incorporated $DGX Shares Sold by Pictet Asset Management Holding SA - MarketBeat

May 01, 2026
pulisher
May 01, 2026

Quest Diagnostics Incorporated $DGX Shares Sold by Danica Pension Livsforsikringsaktieselskab - MarketBeat

May 01, 2026
pulisher
Apr 30, 2026

Quest Diagnostics | SCHEDULE 13G: Others - Moomoo

Apr 30, 2026
pulisher
Apr 30, 2026

Vanguard reports 8.27M Quest Diagnostics shares (NYSE: DGX) stake - Stock Titan

Apr 30, 2026

Quest Diagnostics Inc (DGX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Quest Diagnostics Inc (DGX) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
PREVOZNIK MICHAEL E
SVP & General Counsel
Mar 05 '26
Sale
206.21
3,878
799,682
37,557
Plewman Patrick
SVP for Diagnostic Services
Mar 05 '26
Sale
206.21
2,855
588,730
15,198
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
Mar 04 '26
Sale
204.86
2,628
538,372
13,441
$144.41
price down icon 0.29%
MTD MTD
$1,103.09
price up icon 1.16%
IQV IQV
$167.90
price down icon 0.07%
$203.19
price down icon 0.25%
A A
$114.96
price up icon 0.15%
大文字化:     |  ボリューム (24 時間):